Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases
نویسندگان
چکیده
•Progestins can produce clinical benefit in a subset of women with metastatic endometrial cancer.•Corticosteroid-related effects of megestrol can cause morbidity over the long term.•Norethindrone is a progestin without corticosteroid side effects.•A switch from megestrol to norethindrone decreased toxicity with continued benefit.•A clinical trial of norethindrone for this population of patients would be welcome.
منابع مشابه
نقش گیرنده‌های هورمونی استروژن و پروژسترون در درمان کنسرواتیو آدنوکارسینوم خوب تمایزیافته اندومتر مرحله Ia با مژسترول استات
Background: Surgery is the most effective treatment of well-differentiated endometrial cancer. But using systemic progestins, have been evaluated to treat the young patients with well-differentiated endometrial cancer who wish to preserve their fertility. The aim of this study was the evaluation of megestrol acetate on endometrial adenocarcino-ma with regard to the receptors. Methods: This was...
متن کاملLNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?
(EH) is a common disease affecting women of all ages [1]. It is clinically important because it can cause abnormal uterine bleeding, and can precede, or occur concurrently, with endometrial carcinoma. There are many progestin therapy regimens available for treatment of EH. The main progestational agents are oral pro-gestogens such as norethisterone acetate, megestrol acetate, and medroxyprogest...
متن کاملNew therapies for advanced, recurrent, and metastatic endometrial cancers
Endometrial cancer is the most common gynecologic malignancy in the United States, accounting for 6% of cancers in women. In 2017, an estimated 61,380 women were diagnosed with endometrial cancer, and approximately 11,000 died from this disease. From 1987 to 2008, there was a 50% increase in the incidence of endometrial cancer, with an approximate 300% increase in the number of associated death...
متن کاملبررسی ایمونوهیستوشیمی بروز گیرنده‌های استروژن و پروژسترون در انواع هیپرپلازی و کارسینوم آندومتریویید آندومتر
Background: Endometrial carcinoma (EC) is the most common gynecologic malignancy however, mechanisms underlying its pathogenesis remain obscure. Endometrial carcinoma has been classified into two major categories: type I (related to estrogen or endometrioid adenocarcinoma) and type II (unrelated to estrogen). Estrogen is the main trigger for the abnormal proliferation in the endometrial epithel...
متن کاملBeware of Bone Marrow: Incidental Detection and Primary Diagnosis of Solid Tumours in Bone Marrow Aspiration and Biopsies; A Study of 22 Cases
Background & objective: Introduction: First detection of any solid tumour as metastatic deposits in bone marrow directs clinicians to start searching for the primary tumour. Detection of bone marrow metastasis determines the stage of the malignancy, prognosis, mode of treatment, chemotherapeutic response and follow-up in case of relapse. The aim of the current...
متن کامل